drugset / Trial / NCT06083142
Fecal Microbiota Transplant for Autobrewery Syndrome
Phase 0
Active not recruiting
8 enrolled
Massachusetts General Hospital
National Institutes of Health (NIH) · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to study fecal microbiota transplantation(FMT) by oral capsule in people already diagnosed with auto-brewery syndrome (ABS, also known as gut fermentation syndrome). The main question it aims to answer: Is FMT safe and feasible in this syndrome? Participants will 1. have a "gut cleanout" with oral antibiotics and a colon cleanse, similar to that administered before colonoscopy 2. receive five oral doses of fecal transplant capsules over a week 3. be followed for six months for safety and research samples
Timeline
- Start
- 2025-02-14
- Primary completion
- 2029-08-31
- Completion
- 2030-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fecal microbiota transplantation capsules | Unknown | — | Oral |